Class 4 caution in use-Sandoz Omeprazole

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Sandoz Omeprazole

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPCs) of the specific products listed in this notification.

MHRA Drug alert date: 7th August 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-limited-omeprazole-products-el-24-a-slash-34?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ea1dca7f-9fca-4f37-ae61-6f98b6648de6&utm_content=immediately

Pip code	Product description		Supplier	Batch Numbers
8092710	OMEP DISP TAB 10MG (MEZZOPRAM)	SANDOZ LTD (CPG)		See above link
8092728	OMEP DISP TAB 20MG (MEZZOPRAM)	SANDOZ LTD (CPG)		See above link
8092702	OMEP DISP TAB 40MG (MEZZOPRAM)	SANDOZ LTD (CPG)		See above link
1128016	OMEPRAZOLE CAP 10MG ALM	ALMUS PHARMACEUTICALS LTD		See above link
1128073	OMEPRAZOLE CAP 20MG ALM	ALMUS PHARMACEUTICALS LTD		See above link
Alliance do not stock	OMEPRAZOLE PDR VIAL 40MG	SANDOZ LTD (CPG)		See above link

This is a caution in use only we are not accepting stock returns

Further Information

For more information or medical information queries, please email sandozgb@EU.propharmagroup.com, or telephone: +44 1276 698 101

For stock control queries, please email sales.sandoz-gb@sandoz.com, or telephone: +44 1276 698607